13th Annual UWEB-21 Summer Symposium
Sponsored by the University of Washington Engineered Biomaterials
BEIT 2009 has concluded.
UWEB-21 thanks our sponsors and attendees for their participation.
Check UWEB-21’s Home Page for future event announcements.
BEIT 2009 was sponsored by:
|
 |
 |
 |
 |
 |
 |
Thomas Edison once said: “I’d never invent something if no one would buy it.”
BEIT2009 was a forum where scientist-entrepreneurs described their latest biomaterials innovations that are translating from laboratory to industry to patient.
Topics included technological advances, funding, venture capital, business models, technology transfer, the role of the government and entrepreneur education.
At BEIT2009 attendees were exposed to:
- The scientist-engineer-innovators who are creating tomorrow’s biomaterials and medical devices.
- The entrepreneurs who are translating these developments from academia to industry and the clinic.
- The venture capitalists who are funding these innovations.
- The Federal Government view of translational medicine.
- How large medical device companies view and assess start-ups.
- Academic programs to train entrepreneurs.
Featured Speakers (alphabetical order):
- Stephen Badylak, University of Pittsburgh, ACell Inc.
- Ravi Bellamkonda, Georgia Institute of Technology, Marval Therapeutics Inc.
- Joseph DeSimone, University of North Carolina, Liquidia Technologies
- Gail Naughton, San Diego State University, Histogen Inc.
- Glenn Prestwich, University of Utah, Glycosan Systems
- Buddy Ratner, University of Washington, Inson Inc.
- David Walt, Tufts University, Illumina Inc.
- Robert Ward, DSM Polymer Technology Group
Speakers - Contributed Talks (alphabetical order):
- Kris Aalto, President, Accord Biomaterials, Inc.
- Connie Bourassa-Shaw, University of Washington
- Phillip Fleckman, University of Washington
- Mark Grinstaff, Hyperbranch Medical
- Mark Hoffman, Esq., Partner/Chair, DLA Piper LLP (US)
- Ahmet Hoke, Johns Hopkins University, Ratner Biomedical Inc.
- Janis Machala, University of Washington
- Max Maginness, Healionics Corporation
- Eric Simanek, Texas A&M University, Lone Star Molecular, Inc.
- Pat Stayton, University of Washington
- Gary E. Wnek, Case Western Reserve University
- Paul Yager, University of Washington